Lucid Diagnostics Inc.
NASDAQ:LUCD
1.26 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 4,346 | 2.428 | 0.377 | 0.5 | 0 | 0 | 0 |
| Cost of Revenue
| 7,099 | 8.478 | 3.614 | 0.585 | 0 | 0 | 0 |
| Gross Profit
| -2,753 | -6.05 | -3.237 | -0.085 | 0 | 0 | 0 |
| Gross Profit Ratio
| -0.633 | -2.492 | -8.586 | -0.17 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5,992 | 7.252 | 11.466 | 9.296 | 5.443 | 3.462 | 0.716 |
| General & Administrative Expenses
| 20,156 | 19.254 | 23.685 | 12.778 | 2.837 | 0.959 | 0.615 |
| Selling & Marketing Expenses
| 16,463 | 16.404 | 16.134 | 5.26 | 1.305 | 0 | -0.205 |
| SG&A
| 36,619 | 35.658 | 39.819 | 18.038 | 2.837 | 0.959 | 0.41 |
| Other Expenses
| 688 | -0.478 | 1.649 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 43,299 | 42.432 | 52.934 | 27.334 | 8.28 | 4.421 | 1.126 |
| Operating Income
| -46,052 | -48.482 | -56.171 | -27.419 | -8.28 | -4.421 | -1.126 |
| Operating Income Ratio
| -10.596 | -19.968 | -148.995 | -54.838 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 523 | -4.184 | 0 | -0.659 | 0 | 0 | -0 |
| Income Before Tax
| -45,529 | -52.666 | -56.171 | -28.078 | -8.28 | -4.421 | -1.126 |
| Income Before Tax Ratio
| -10.476 | -21.691 | -148.995 | -56.156 | 0 | 0 | 0 |
| Income Tax Expense
| 7,496 | 0 | 1.708 | 0.659 | -8.28 | -4.421 | -1.689 |
| Net Income
| -45.529 | -52.666 | -56.171 | -28.737 | -8.28 | -4.421 | -1.126 |
| Net Income Ratio
| -0.01 | -21.691 | -148.995 | -57.474 | 0 | 0 | 0 |
| EPS
| -0.75 | -1.26 | -1.55 | -0.82 | -0.22 | -0.12 | -0.03 |
| EPS Diluted
| -0.75 | -1.26 | -1.55 | -0.82 | -0.22 | -0.12 | -0.03 |
| EBITDA
| -46,052 | -49.751 | -54.235 | -27.415 | 0 | 0 | 0.563 |
| EBITDA Ratio
| -10.596 | -20.491 | -143.859 | -54.83 | 0 | 0 | 0 |